We aim to demonstrate how effective Embrace and the Alert App are in detecting movement and EDA patterns that might be related with tonic-clonic seizures and alerting caregivers in real-world conditions.
It’s necessary to test on a large number of people to ensure that any benefit derived from the Embrace is not random. The clinical trial is overseen by a review board which protects the participants by monitoring the trial.
Our goal is to produce objective evidence that our detection algorithm and alerting system facilitates intervention, and helps patients with tonic-clonic seizures regain independence. We also hope to further the understanding of epilepsy, and obtain useful data for epilepsy management.
If you are interested in participating, please visit How can I join the clinical trial?
By participating in the clinical trial you are helping advance scientific progress in the Epilepsy research space. You are also contributing to an improved user experience with the Embrace (such as reduced false alarm rate and better activity estimation in the Mate App).